William Blair & Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.3M Buy
153,247
+68,893
+82% +$6.6M 0.04% 296
2025
Q4
$8.1M Buy
84,354
+5,499
+7% +$534K 0.02% 408
2025
Q3
$7.51M Sell
78,855
-3,824
-5% -$352K 0.02% 426
2025
Q2
$7.21M Buy
82,679
+442
+0.5% +$37.5K 0.02% 417
2025
Q1
$7.39M Sell
82,237
-12,295
-13% -$1.1M 0.02% 390
2024
Q4
$7.55M Sell
94,532
-317
-0.3% -$27.4K 0.02% 396
2024
Q3
$8.54M Sell
94,849
-10,229
-10% -$861K 0.03% 376
2024
Q2
$8.27M Sell
105,078
-34,749
-25% -$2.85M 0.03% 363
2024
Q1
$12.2M Buy
139,827
+8,513
+6% +$727K 0.04% 299
2023
Q4
$10.8M Sell
131,314
-2,309
-2% -$176K 0.04% 306
2023
Q3
$10.5M Buy
133,623
+29,359
+28% +$2.46M 0.04% 293
2023
Q2
$9.19M Sell
104,264
-5,722
-5% -$493K 0.03% 325
2023
Q1
$8.87M Sell
109,986
-27,286
-20% -$2.22M 0.04% 324
2022
Q4
$10.7M Sell
137,272
-79,093
-37% -$6.41M 0.05% 286
2022
Q3
$17.5M Sell
216,365
-21,622
-9% -$1.94M 0.08% 201
2022
Q2
$21.4M Sell
237,987
-197,018
-45% -$20M 0.09% 187
2022
Q1
$48.3M Sell
435,005
-45,263
-9% -$4.78M 0.17% 132
2021
Q4
$49.7M Sell
480,268
-8,788
-2% -$1.02M 0.16% 135
2021
Q3
$61.3M Buy
489,056
+3,902
+0.8% +$505K 0.21% 110
2021
Q2
$60.2M Buy
485,154
+276
+0.1% +$34.7K 0.21% 110
2021
Q1
$57.3M Sell
484,878
-10,013
-2% -$1.17M 0.22% 113
2020
Q4
$58M Sell
494,891
-8,036
-2% -$885K 0.21% 103
2020
Q3
$52.3M Buy
502,927
+17,455
+4% +$1.75M 0.22% 97
2020
Q2
$44.5M Buy
485,472
+25,337
+6% +$2.43M 0.21% 108
2020
Q1
$41.5M Buy
460,135
+23,961
+5% +$2.55M 0.26% 88
2019
Q4
$49.5M Buy
436,174
+37,040
+9% +$4.06M 0.25% 91
2019
Q3
$43.4M Buy
399,134
+3,362
+0.8% +$351K 0.25% 93
2019
Q2
$38.5M Buy
395,772
+7,398
+2% +$675K 0.22% 105
2019
Q1
$35.4M Buy
388,374
+2,256
+0.6% +$202K 0.22% 108
2018
Q4
$35.1M Buy
386,118
+7,596
+2% +$710K 0.26% 96
2018
Q3
$37.2M Buy
378,522
+34,096
+10% +$3.15M 0.23% 106
2018
Q2
$29.5M Buy
344,426
+38,555
+13% +$3.22M 0.2% 118
2018
Q1
$24.5M Sell
305,871
-9,402
-3% -$776K 0.17% 125
2017
Q4
$25.5M Buy
315,273
+47,395
+18% +$3.8M 0.17% 134
2017
Q3
$20.8M Sell
267,878
-78,325
-23% -$6.5M 0.16% 146
2017
Q2
$30.7M Buy
346,203
+10,181
+3% +$858K 0.23% 110
2017
Q1
$27.1M Sell
336,022
-31,190
-8% -$2.44M 0.22% 118
2016
Q4
$26.2M Sell
367,212
-19,077
-5% -$1.5M 0.23% 112
2016
Q3
$33.4M Buy
386,289
+5,663
+1% +$493K 0.3% 90
2016
Q2
$33M Buy
380,626
+76,091
+25% +$6.15M 0.31% 89
2016
Q1
$22.8M Buy
304,535
+29,456
+11% +$2.22M 0.22% 124
2015
Q4
$21.2M Buy
275,079
+20,870
+8% +$1.57M 0.2% 131
2015
Q3
$17M Sell
254,209
-61,023
-19% -$4.49M 0.15% 165
2015
Q2
$23.4M Sell
315,232
-157,540
-33% -$12M 0.03% 576
2015
Q1
$36.9M Buy
472,772
+154,351
+48% +$11.7M 0.06% 406
2014
Q4
$23M Buy
318,421
+33,272
+12% +$2.31M 0.04% 540
2014
Q3
$17.7M Buy
285,149
+81,697
+40% +$5.19M 0.03% 620
2014
Q2
$13M Buy
203,452
+65,322
+47% +$3.97M 0.02% 763
2014
Q1
$8.5M Buy
138,130
+9,775
+8% +$569K 0.01% 859
2013
Q4
$7.37M Sell
128,355
-10,111
-7% -$573K 0.01% 854
2013
Q3
$7.37M Sell
138,466
-6,467
-4% -$348K 0.01% 818
2013
Q2
$7.46M Buy
+144,933
New +$7.16M 0.01% 794

Other funds holding MDT

William Blair & Company's MDT Position: Q1 2026 in Review

William Blair & Company increased its Medtronic (MDT) stake by 82% in Q1 2026, buying an estimated $6.6M and bringing the position to 153,247 shares worth $13.3M. The position accounts for 0.04% of the portfolio, ranked #296.

William Blair & Company first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.3M in Q3 2021. 2,237 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • William Blair & Company held 153,247 shares of Medtronic worth $13.3M as of Q1 2026.
  • William Blair & Company bought 68,893 Medtronic shares in Q1 2026, an estimated $6.6M.
  • Medtronic made up 0.04% of William Blair & Company's portfolio in Q1 2026, its #296 holding.
  • William Blair & Company first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Medtronic position peaked at $61.3M in Q3 2021.
  • 2,237 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.